Riskpilot← Back to searchSign inGet full accessVETPHARM LØGSTØR ApS
APSActiveCVR 30272625Østerbrogade 23Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200711 employees
Revenue 2024
DKK 7,3M
+1% vs 2023
EBITDA margin
37.1%
+15% vs 2023
Equity ratio
15.4%
Financial strength
Net profit 2024
DKK 2,3M
+19% vs 2023
| Revenue | DKK 7,3M | +1% |
| EBITDA | DKK 2,7M | +15% |
| Net profit | DKK 2,3M | +19% |
| Total assets | DKK 63M | +7% |
| Equity | DKK 9,7M | +12% |
| Employees | 11 | — |
Legal name
VETPHARM LØGSTØR ApS
CVR number
30272625
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. februar 2007
Share capital
DKK 125.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren alene.
Company purpose
Selskabets formål er at drive handel med veterinære lægemidler til produktionsdyr i landbrug, investering og servicevirksomhed eller anden dermed efter direktionens skøn beslægtet virksomhed.
Address
Østerbrogade 23
Phone
+4598673722
Email
logstor@vetpharm.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.522 | 5.988 | 4.903 | 5.908 | 6.634 | 6.883 | 7.030 | 7.131 | 8.017 | 7.104 | 7.046 | 7.181 | 7.279 |
| Staff expenses | -4.942 | -4.627 | -4.621 | -4.979 | -5.422 | -5.439 | -5.691 | -5.243 | -5.621 | -5.715 | -5.631 | -4.839 | -4.580 |
| EBITDA | 1.581 | 1.361 | 282 | 929 | 1.212 | 1.445 | 1.340 | 1.887 | 2.395 | 1.389 | 1.416 | 2.342 | 2.698 |
| Depreciation & amort. | -144 | -135 | -134 | -97 | -91 | -91 | -85 | -3 | -76 | -76 | -76 | -76 | -51 |
| EBIT | 1.436 | 1.227 | 148 | 832 | 1.121 | 1.353 | 1.255 | 1.885 | 2.319 | 1.313 | 1.340 | 2.266 | 2.648 |
| Net financials | 89 | 35 | -16 | 33 | 33 | -3 | -36 | 1 | -28 | -21 | 4 | 186 | 260 |
| Profit before tax | 1.525 | 1.262 | 132 | 865 | 1.155 | 1.350 | 1.219 | 1.886 | 2.292 | 1.292 | 1.343 | 2.453 | 2.908 |
| Tax | 383 | 317 | 33 | 204 | 255 | 298 | 269 | 416 | 505 | 284 | 296 | 540 | 641 |
| Net profit | 1.142 | 945 | 99 | 661 | 900 | 1.053 | 950 | 1.471 | 1.787 | 1.008 | 1.048 | 1.912 | 2.267 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 39.178 | 39.390 | 45.784 | 53.857 | 54.620 | 62.556 | 58.647 | 57.028 | 72.530 | 57.689 | 61.864 | 58.684 | 63.025 |
| Equity | 4.054 | 4.256 | 3.741 | 4.338 | 4.808 | 5.276 | 5.542 | 6.395 | 7.226 | 7.072 | 7.465 | 8.696 | 9.720 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 35.109 | 35.130 | 42.037 | 49.513 | 49.808 | 57.281 | 53.105 | 50.624 | 65.294 | 50.611 | 54.399 | 49.988 | 53.305 |
| Total debt | 35.109 | 35.130 | 42.037 | 49.513 | 49.808 | 57.281 | 53.105 | 50.624 | 65.294 | 50.611 | 54.399 | 49.988 | 53.305 |
EBITDA margin
37.1%
This company
15.8%
Market median
+135% vs market
20122024
Equity ratio
15.4%
This company
38.2%
Market median
-60% vs market
20122024
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
20122024
Net profit margin
31.1%
This company
8.1%
Market median
+284% vs market
20122024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20122024
Debt / equity
5.48×
This company
0.62×
Market median
-784% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LH Management | Management | 2007 | — | — |
GH Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
INWET HOLDING ApS | Company | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Løvegener Holding ApSGRAVERS OG HANNE GRAVERSEN HOLDING ApSINWET HOLDING ApS
VETPHARM LØGSTØR ApS (this company)Board members of VETPHARM LØGSTØR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lone Haahr | Management | 0 companies |
| Gravers Hedegaard Graversen | Management | 0 companies |